Global intelligent asthma monitoring devices market

Intelligent Asthma Monitoring Devices Market Size, Share, Growth Analysis, By Product(Wearable asthma monitoring devices, smart inhalers), By End use(Hospitals, clinics) - Industry Forecast 2024-2031

Report ID: SQMIG35C2023 | Region: Global | Published Date: July, 2001
Pages: 157 | Tables: 66 | Figures: 75

Share your requirements to help us to customize the report.
   I acknowledge that I have read the Privacy Policy
Confidentiality

We respect your privacy rights and safeguard your personal information. We prevent the disclosure of personal information to third parties.

Analyst Support
$5,300
BUY NOW GET FREE SAMPLE

FAQs

Intelligent Asthma Monitoring Devices Market size was valued at USD 310.63 million in 2019 and is poised to grow from USD 566.26 million in 2023 to USD 1696.7 million by 2031, growing at a CAGR of 25.1% in the forecast period (2024-2031).

intelligent asthma monitoring device market is highly fragmented. The players adopted the key strategies to strengthen their position in the market which is as follows- product launches, mergers & acquisitions, joint venture, and geographical expansion. 'Adherium Limited', 'AstraZeneca', 'Boehringer Ingelheim International GmbH', 'Cohero Health, Inc.', 'GlaxoSmithKline plc', 'Health Care Originals, Inc.', 'Inspiro Medical Ltd.', 'Ivivi Health Sciences LLC', 'Koko Health, Inc.', 'Medical International Research USA, Inc.', 'NuvoAir AB', 'Pneuma Respiratory, Inc.', 'Propeller Health', 'ResMed', 'Sensirion AG', 'Teva Pharmaceuticals Industries Ltd.', 'Thorasys Thoracic Medical Systems Inc.', 'Vitalograph Ltd.', 'Volansys Technologies Pvt. Ltd.', 'Zephyr Sleep Technologies'

Increasing pollution across the globe is the major factor that contributes to the increasing number of people suffering from asthma. This condition helps to boost sales of intelligent asthma monitoring devices. According to the Centers for Disease Control and Prevention (CDC), over 27 million people in the U.S. suffered from asthma. It was one of the chronic conditions in children, with a prevalence of 1 in every 12 children. According to Asthma UK, there are over 300 million people suffering from asthma and the number is anticipated to rise by over 100 million by 2025. People’s awareness about the advantages of asthma monitoring devices, technological advancement, and increasing company focus are the factors that help to propel the market growth. Smart inhalers include a dry powdered inhaler and metered dose inhaler. Key players are embracing the use of these smart inhalers in order to enhance the management of asthma and also to improve the effectiveness of the prescribed medications that helps to boost the market growth.

ADAMM smart patch is one of the wearables that is used to monitor symptoms like cough, respiration rate, and presence of wheeze. This device is deviate from the individnormsnorm, the wearable vibrates to indicate the user of the deviation and it sends a text notification to a designated person.

intelligent asthma monitoring devices market can be segmented into five major regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.

Related Reports

Esoteric Testing Market
Buy Now GET FREE SAMPLE
Antibody Therapy Market
Buy Now GET FREE SAMPLE
Minimally Invasive Surgery Market
Buy Now GET FREE SAMPLE
Adult Diapers Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global intelligent asthma monitoring devices market

Product ID: SQMIG35C2023

$5,300
BUY NOW GET FREE SAMPLE